 | • レポートコード：GIR-23F3726 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global 7-Valent Pneumococcal Vaccine Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の7価肺炎球菌ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 7価肺炎球菌ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・単回投与バイアル、プレフィルドシリンジ アプリケーション別セグメントは次のように区分されます。 ・病院、診療所 世界の7価肺炎球菌ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Merck 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 7価肺炎球菌ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：単回投与バイアル、プレフィルドシリンジ - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所 - 世界の7価肺炎球菌ワクチン市場規模・予測 - 世界の7価肺炎球菌ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：単回投与バイアル、プレフィルドシリンジ ・アプリケーション別分析2017年-2028年：病院、診療所 ・7価肺炎球菌ワクチンの北米市場分析 - 7価肺炎球菌ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 7価肺炎球菌ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・7価肺炎球菌ワクチンのヨーロッパ市場分析 - ：7価肺炎球菌ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：7価肺炎球菌ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・7価肺炎球菌ワクチンのアジア太平洋市場分析 - 7価肺炎球菌ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 7価肺炎球菌ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・7価肺炎球菌ワクチンの南米市場分析 - 7価肺炎球菌ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 7価肺炎球菌ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・7価肺炎球菌ワクチンの中東・アフリカ市場分析 - 7価肺炎球菌ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 7価肺炎球菌ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The 7-Valent Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global 7-Valent Pneumococcal Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the 7-Valent Pneumococcal Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Dose Vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of 7-Valent Pneumococcal Vaccine include Merck, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
7-Valent Pneumococcal Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Dose Vial
Pre-filled Syringe
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global 7-Valent Pneumococcal Vaccine market are listed below:
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 7-Valent Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 7-Valent Pneumococcal Vaccine, with price, sales, revenue and global market share of 7-Valent Pneumococcal Vaccine from 2019 to 2022.
Chapter 3, the 7-Valent Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 7-Valent Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and 7-Valent Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of 7-Valent Pneumococcal Vaccine.
Chapter 13, 14, and 15, to describe 7-Valent Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 7-Valent Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 7-Valent Pneumococcal Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
1.3.1 Overview: Global 7-Valent Pneumococcal Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global 7-Valent Pneumococcal Vaccine Market Size & Forecast
1.4.1 Global 7-Valent Pneumococcal Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global 7-Valent Pneumococcal Vaccine Sales in Volume (2017-2028)
1.4.3 Global 7-Valent Pneumococcal Vaccine Price (2017-2028)
1.5 Global 7-Valent Pneumococcal Vaccine Production Capacity Analysis
1.5.1 Global 7-Valent Pneumococcal Vaccine Total Production Capacity (2017-2028)
1.5.2 Global 7-Valent Pneumococcal Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 7-Valent Pneumococcal Vaccine Market Drivers
1.6.2 7-Valent Pneumococcal Vaccine Market Restraints
1.6.3 7-Valent Pneumococcal Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck 7-Valent Pneumococcal Vaccine Product and Services
2.1.4 Merck 7-Valent Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 7-Valent Pneumococcal Vaccine Breakdown Data by Manufacturer
3.1 Global 7-Valent Pneumococcal Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global 7-Valent Pneumococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in 7-Valent Pneumococcal Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 7-Valent Pneumococcal Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 7-Valent Pneumococcal Vaccine Manufacturer Market Share in 2021
3.5 Global 7-Valent Pneumococcal Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and 7-Valent Pneumococcal Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 7-Valent Pneumococcal Vaccine Market Size by Region
4.1.1 Global 7-Valent Pneumococcal Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2028)
4.2 North America 7-Valent Pneumococcal Vaccine Revenue (2017-2028)
4.3 Europe 7-Valent Pneumococcal Vaccine Revenue (2017-2028)
4.4 Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue (2017-2028)
4.5 South America 7-Valent Pneumococcal Vaccine Revenue (2017-2028)
4.6 Middle East and Africa 7-Valent Pneumococcal Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global 7-Valent Pneumococcal Vaccine Sales in Volume by Type (2017-2028)
5.2 Global 7-Valent Pneumococcal Vaccine Revenue by Type (2017-2028)
5.3 Global 7-Valent Pneumococcal Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global 7-Valent Pneumococcal Vaccine Sales in Volume by Application (2017-2028)
6.2 Global 7-Valent Pneumococcal Vaccine Revenue by Application (2017-2028)
6.3 Global 7-Valent Pneumococcal Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America 7-Valent Pneumococcal Vaccine Sales by Type (2017-2028)
7.2 North America 7-Valent Pneumococcal Vaccine Sales by Application (2017-2028)
7.3 North America 7-Valent Pneumococcal Vaccine Market Size by Country
7.3.1 North America 7-Valent Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe 7-Valent Pneumococcal Vaccine Sales by Type (2017-2028)
8.2 Europe 7-Valent Pneumococcal Vaccine Sales by Application (2017-2028)
8.3 Europe 7-Valent Pneumococcal Vaccine Market Size by Country
8.3.1 Europe 7-Valent Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific 7-Valent Pneumococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific 7-Valent Pneumococcal Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America 7-Valent Pneumococcal Vaccine Sales by Type (2017-2028)
10.2 South America 7-Valent Pneumococcal Vaccine Sales by Application (2017-2028)
10.3 South America 7-Valent Pneumococcal Vaccine Market Size by Country
10.3.1 South America 7-Valent Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa 7-Valent Pneumococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa 7-Valent Pneumococcal Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of 7-Valent Pneumococcal Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of 7-Valent Pneumococcal Vaccine
12.3 7-Valent Pneumococcal Vaccine Production Process
12.4 7-Valent Pneumococcal Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 7-Valent Pneumococcal Vaccine Typical Distributors
13.3 7-Valent Pneumococcal Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global 7-Valent Pneumococcal Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global 7-Valent Pneumococcal Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck 7-Valent Pneumococcal Vaccine Product and Services
Table 6. Merck 7-Valent Pneumococcal Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global 7-Valent Pneumococcal Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global 7-Valent Pneumococcal Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in 7-Valent Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global 7-Valent Pneumococcal Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and 7-Valent Pneumococcal Vaccine Production Site of Key Manufacturer
Table 12. 7-Valent Pneumococcal Vaccine New Entrant and Capacity Expansion Plans
Table 13. 7-Valent Pneumococcal Vaccine Mergers & Acquisitions in the Past Five Years
Table 14. Global 7-Valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)
Table 15. Global 7-Valent Pneumococcal Vaccine Sales by Region (2023-2028) & (K Units)
Table 16. Global 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 17. Global 7-Valent Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 18. Global 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 19. Global 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 20. Global 7-Valent Pneumococcal Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 21. Global 7-Valent Pneumococcal Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 22. Global 7-Valent Pneumococcal Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 23. Global 7-Valent Pneumococcal Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 24. Global 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 25. Global 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 26. Global 7-Valent Pneumococcal Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 27. Global 7-Valent Pneumococcal Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 28. Global 7-Valent Pneumococcal Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 29. Global 7-Valent Pneumococcal Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 30. North America 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 31. North America 7-Valent Pneumococcal Vaccine Sales by Country (2023-2028) & (K Units)
Table 32. North America 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 33. North America 7-Valent Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 34. North America 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 35. North America 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 36. North America 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. North America 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Europe 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. Europe 7-Valent Pneumococcal Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe 7-Valent Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. Europe 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. Europe 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. Europe 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. South America 7-Valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. South America 7-Valent Pneumococcal Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. South America 7-Valent Pneumococcal Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. South America 7-Valent Pneumococcal Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. South America 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. South America 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. South America 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. South America 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. 7-Valent Pneumococcal Vaccine Raw Material
Table 71. Key Manufacturers of 7-Valent Pneumococcal Vaccine Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. 7-Valent Pneumococcal Vaccine Typical Distributors
Table 75. 7-Valent Pneumococcal Vaccine Typical Customers
List of Figures
Figure 1. 7-Valent Pneumococcal Vaccine Picture
Figure 2. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Type in 2021
Figure 3. Single Dose Vial
Figure 4. Pre-filled Syringe
Figure 5. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global 7-Valent Pneumococcal Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global 7-Valent Pneumococcal Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global 7-Valent Pneumococcal Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global 7-Valent Pneumococcal Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global 7-Valent Pneumococcal Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global 7-Valent Pneumococcal Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. 7-Valent Pneumococcal Vaccine Market Drivers
Figure 15. 7-Valent Pneumococcal Vaccine Market Restraints
Figure 16. 7-Valent Pneumococcal Vaccine Market Trends
Figure 17. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. 7-Valent Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 7-Valent Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 7-Valent Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America 7-Valent Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe 7-Valent Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America 7-Valent Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global 7-Valent Pneumococcal Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global 7-Valent Pneumococcal Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global 7-Valent Pneumococcal Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific 7-Valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America 7-Valent Pneumococcal Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America 7-Valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa 7-Valent Pneumococcal Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa 7-Valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa 7-Valent Pneumococcal Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of 7-Valent Pneumococcal Vaccine in 2021
Figure 76. Manufacturing Process Analysis of 7-Valent Pneumococcal Vaccine
Figure 77. 7-Valent Pneumococcal Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
| 【7価肺炎球菌ワクチンについて】 7価肺炎球菌ワクチンについて説明いたします。このワクチンは、肺炎球菌（Streptococcus pneumoniae）による感染症を予防するために開発されたもので、特に小児や高齢者など、感染症にかかりやすい人々を対象としています。肺炎球菌は、肺炎や髄膜炎、中耳炎など、さまざまな重篤な疾患の原因となる細菌です。そのため、これに対する予防策としてのワクチンの重要性は非常に高いと言えます。 7価肺炎球菌ワクチンは、特定の7種類の肺炎球菌に対する免疫応答を引き起こすために設計されたワクチンです。これらの菌は、肺炎球菌に関連する感染症の大部分を引き起こす主要な血清型として知られています。特に、これらの血清型によって引き起こされる疾患は、重篤な感染を伴う可能性が高く、特に子供や免疫力の低下した高齢者にとって致命的となることがあります。 このワクチンの特徴としては、まず第一に、体内に導入された後、抗体を生成することにより、特定の肺炎球菌に対して免疫を獲得できる点が挙げられます。接種後、体内はこれらの病原菌に対する防御メカニズムを構築し、将来同様の病原菌に感染した際に素早く反応できるようになります。また、7価肺炎球菌ワクチンは、従来のワクチンに比べて副反応が少なく、受け入れやすいという利点も持っています。 7価肺炎球菌ワクチンは、その名前の通り、7種類の肺炎球菌血清型に基づいています。これらの具体的な血清型には、例えば血清型4、6B、9V、14、18C、19F、23Fが含まれています。これらの型は、肺炎球菌の感染症の主要な原因となるものであり、7価ワクチンの接種によって、これらの型に対する抗体を得ることができます。 用途としては、主に小児における肺炎球菌感染症の予防が挙げられます。特に小児は免疫系が未発達であるため、肺炎球菌に感染しやすく、重篤な症状を呈することも少なくありません。したがって、若年層への接種が特に重要なのです。また、成人や高齢者においても、慢性疾患を抱えている方や免疫系が弱い方にとっては、感染リスクが高いため、接種が推奨されることがあります。 7価肺炎球菌ワクチンは、ワクチン接種プログラムにおいて重要な役割を果たしています。特に、全国的なワクチンプログラムの一環として、多くの国で小児に対する定期接種が行われており、これによって肺炎球菌による疾患の発生を大幅に減少させてきました。さらに、ワクチン接種率が高まることで、集団免疫の効果も期待できます。 関連技術としては、ワクチン製造の分野において、より効果的なワクチンの開発が進められています。例えば、従来の7価ワクチンに加え、13価や15価など、より多くの血清型をカバーするワクチンも登場しています。これにより、さらなる感染症予防の効果が期待されており、ワクチンの効果を高めるための研究は日々進行しています。 また、肺炎球菌ワクチンに関しては、様々な形態が存在し、単独ワクチンとして使用されるだけでなく、他のワクチン（例えば、インフルエンザワクチンなど）と併用して接種されることもあります。このように、ワクチン接種は複合的なアプローチが求められる領域となっています。そして、ワクチンに関する研究も日々進化しており、新たな技術やアプローチが投入されることで、より効果的な予防手段が確立されていくことが期待されています。 最後に、7価肺炎球菌ワクチンは、公共の健康政策においても重要な位置付けを持っています。感染症の予防は、個人だけでなく、地域社会や国全体にとっても大きな関心事であるため、今後もこの分野への取り組みが求められます。感染症の流行を未然に防ぎ、健康的な社会を維持するためには、ワクチン接種が不可欠であるという認識を持ち続けることが重要です。 このように、7価肺炎球菌ワクチンは、肺炎球菌による疾患予防のために不可欠なツールであり、その効果や技術の進展によって、さらなる感染症予防の向上が期待されています。予防接種を通じて、全ての人々が健康であるように、この分野における努力が続けられることが望まれます。 |